C07C 225/04
The carbon skeleton being saturated
Official title: the carbon skeleton being saturated
C07C225/04 (The carbon skeleton being saturated) appears on 131 US grants and 162 published applications in this corpus.
Search patents in C07C- Granted patents
- 131
- Published applications
- 162
- Assignees
- 112
- Inventors
- 396
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 5 |
| 2003 | 2 | 2 |
| 2004 | 2 | 7 |
| 2005 | 2 | 5 |
| 2006 | 3 | 7 |
| 2007 | 3 | 2 |
| 2008 | 4 | 12 |
| 2009 | 2 | 5 |
| 2010 | 5 | 7 |
| 2011 | 5 | 7 |
| 2012 | 3 | 2 |
| 2013 | 8 | 9 |
| 2014 | 9 | 9 |
| 2015 | 6 | 11 |
| 2016 | 11 | 10 |
| 2017 | 5 | 9 |
| 2018 | 4 | 7 |
| 2019 | 9 | 12 |
| 2020 | 5 | 2 |
| 2021 | 3 | 10 |
| 2022 | 5 | 6 |
| 2023 | 2 | 4 |
| 2024 | 4 | 4 |
| 2025 | 4 | 3 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Use of D9-methadone for postoperative pain relief31 Mar 2026US 12,590,054 B2Board of Regents, The University of Texas System
- Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof4 Nov 2025US 12,459,883 B2Kynan Duke IP, LLC
- Methods and materials for increasing level of phosphorylated AMPK protein30 Sep 2025US 12,428,378 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof26 Mar 2026US 2026/0085033 A1DeuteRx, LLC
- Application of compound or traditional chinese medicine extract in preparation of nucleic acid delivery agent, and related products1 Jan 2026US 2026/0000768 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
Most cited
By later US patents
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion114US 9,732,031 B2DeuteRx, LLC · 2017
- Ligands for metals and improved metal-catalyzed processes based thereon100US 6,395,916 B1Massachusetts Institute of Technology · 2002
- Ligands for metals and improved metal-catalyzed processes based thereon93US 7,223,879 B2Massachusetts Institute of Technology · 2007
- 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects90US 6,248,737 B1Gruenenthal GmbH · 2001